Samsung Biologics Co.,Ltd. (207940.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 78.38T |
| Enterprise Value | 79.16T |
| P/E Ratio | 31.36 |
| PEG Ratio | 0.67 |
| Price/Sales Ratio | 13.05 |
| Price/Book Ratio | 7.43 |
| Enterprise/Revenue | 13.2 |
| Enterprise/EBITDA | 20.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.42 |
| Operating Margin | 0.42 |
| Return On Assets | 0.16 |
| Return On Equity | 0.19 |
| Revenue | 4.56T |
| Revenue/Share | 97,660.42 |
| Gross Profit | 2.48T |
| EBITDA | 2.78T |
| Net Income | 1.78T |
| Diluted EPS | 38,588 |
| Total Cash | 1.62T |
| Total Cash/Share | 35,042.45 |
| Total Debt | 1.19T |
| Total Debt/Equity | 0.15 |
| Current Ratio | 1.7 |
| Book Value Per Share | 171,341.6 |
| 52-Week Change | -16.54 |
| 52-Week High | 1.99M |
| 52-Week Low | 1.23M |
| Moving Average 50 Days | 1.44M |
| Moving Average 200 Days | 1.64M |
| Average Volume | 60,760 |
| Shares Outstanding | 46.29M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 650391:1000000 |
| Last Split Date | October 30, 2025 |